TickerFactsScreenerDevelopers

OCULAR THERAPEUTIX, INC (OCUL) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $457.0K2018: $465.0K2019: $2.33M2020: $2.08M2021: $4.41M2022: $4.54M2023: $5.28M2024: $5.63M2025: $6.57M$6.57M
2017Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$6.57M+16.9%
2024$5.63M+6.5%
2023$5.28M+16.3%
2022$4.54M+3.0%
2021$4.41M+111.5%
2020$2.08M-10.4%
2019$2.33M+400.0%
2018$465.0K+1.8%
2017$457.0K—